Advances in Chimeric Antigen Receptor (CAR) T Cell Therapy for Multiple Myeloma
Advances in Chimeric Antigen Receptor (CAR) T Cell Therapy for Multiple Myeloma Multiple myeloma (MM) is a malignant plasma cell disease and the second most common hematological malignancy. Current...